Stockreport

Inhibrx cancer drug reportedly drawing interest of Merck and rivals [Seeking Alpha]

Inhibrx Biosciences, Inc.  (INBX) 
PDF Pharmaceutical ( OPHLF ) of Japan, are seeking agreements with Inhibrx Biosciences ( INBX ) for a cancer medication that could be valued at more than $8B, Reuters report [Read more]